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Abstract
The detrimental effects of maternal under-nutrition during gestation on fetal development are well known with an 
increased propensity of metabolic disorders identified in the adult offspring. Understanding exactly how and by which 
molecular pathways inadequate nutrition can impact upon offspring phenotype is critical and necessary for the 
development of treatment methods and ultimately prevention of any negative health effects. Myostatin, a negative 
regulator of muscle development, has recently been shown to effect glucose homeostasis and fat deposition. The 
involvement of myostatin in glucose metabolism and adipogenesis thus supports its ability to act in the continued 
alterations to the postnatal phenotype of the offspring. This hypothesis was examined in the current study using a 
trans-generational gestationally under-nourished rat model exposed to a high-fat (HF) diet post-weaning. The body 
weight, body fat, plasma glucose and insulin concentrations of the offspring, both male and female, were investigated 
in relation to the protein expression of myostatin and its main inhibitor; follistatin like-3 (FSTL-3), in skeletal muscle of 
mature offspring. Sexual dimorphism was clearly evident in the majority of these measures, including myostatin and 
FSTL-3 expression. Generally males displayed higher (P < 0.05) myostatin precursor and dimer expression than females, 
which was especially apparent (P < 0.01) in both chow and HF trans-generationally undernourished (UNAD) groups. In 
females only, myostatin precursor and dimer expression was altered by both trans-generational under-nutrition and 
postnatal diet. Overall FSTL-3 expression did not differ between sexes, although difference between sexes within 
certain treatments and diets were evident. Most notably, HF fed UNAD females had higher (P < 0.05) FSTL-3 expression 
than HF fed UNAD males. The former group also displayed higher (P < 0.01) FSTL-3 expression compared to all other 
female groups. In summary, myostatin may prove to be a key mediator of the effects of inadequate prenatal nutrition, 
independently or in combination with a high-fat postnatal diet on offspring phenotype. Consequently, further study of 
myostatin may provide a novel therapeutic pathway for the treatment of metabolic disorders; however, it is vital that 
the influence of nutrition and gender should be taken into consideration.
Introduction
Myostatin initially designated as growth differentiation
factor 8 (GDF-8), is a distinctive member of the TGF-β
super-family, retaining many of the characteristic features
found in this family [1]. The functional importance of
m y o s t a t i n  i s  i n f e r r e d  b y  t h e  h i g h  l e v e l  o f  s e q u e n c e
homology and conservation seen across a number of spe-
cies. Synthesized as a precursor protein, myostatin is pro-
teolytically cleaved twice to release the biologically
mature form of myostatin, with dimerisation of the
mature protein creating the active form of myostatin [1].
The binding of the myostatin dimer to its receptor
(ActRIIB) initiates the Smad mediated signaling pathway,
which results in the transcription and expression of genes
needed to mediate the negative regulation of muscle
development. Myostatin function is controlled by a num-
ber of inhibitors, the most potent being follistatin like-3
(FSTL-3) [2].
Myostatin was initially identified as a negative regulator
of muscle development where its inactivation in mice
resulted in offspring with a two to three-fold increase in
muscle mass [3]. Subsequently, myostatin was identified
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to affect glucose uptake in the human placenta [4].
Recently, altered placenta myostatin concentrations were
identified in developmentally programmed rat model that
supports a role as a mediator of this phenomenon [5].
Myostatin has also been shown to be crucial in the modu-
lation of glucose homeostasis and adipogenesis [6,7]. The
aim of this study was to utilise a model of trans-genera-
tional maternal under-nutrition to investigate potential
sexual dimorphic changes in the expression of myostatin
and FSTL-3 in rat skeletal muscle.
Materials and methods
The animal model depicted (Figure 1) was based upon an
established model of under-nutrition [8-10]. Briefly, vir-
gin female Wistar rats (F0) reared on an ad libitum (AD)
standard chow diet (2018 Teklad Global Rodent Diet; Bic-
ester, UK) were mated at D120 ± 5 of age with males also
fed an AD standard chow diet. Following confirmation of
mating, the females were individually housed and
received either an AD (AD group) or 30% of the AD chow
diet (UN group) throughout gestation. During lactation
dams of both groups were on an AD diet. Litter size was
standardized on D1 to 10 pups per litter to standardize
nutrition until weaning. Female offspring from these
p r e gn a n c i e s  ( F 1 )  w e r e  w e a n ed  a n d  f ed  c h o w  A D  u n t i l
D120 ± 5 of age before being mated with AD males and
fed either AD or UN during gestation. Resulting in three
groups ADAD, ADUN and UNAD; UNUN animals were
not bred for ethical reasons.
F1 females litter size was standardized on D1 to 10
pups, 5 males and 5 females where possible. All these F2
pups were nursed by their own dams that were fed AD
until weaning (D22). At weaning half the offspring from
each of the three groups were fed either a chow or high
fat (HF, 60% kcal as fat; D12492 Research Diets Inc, NJ,
USA) diet ad libitum until being euthanized at D140. The
b o d y  w e i g h t s  o f  F 2  a n i m a l s  w e r e  r e c o r d e d  f r o m  b i r t h
until D140. On D130, body measurements and composi-
tion were determined in F2 animals (n = 10 per sex per
diet per group) by DEXA using a LUNAR Prodigy Scan-
ner (GE Medical Systems, WI, USA). On D140 after an
overnight fast, the animals were euthanised via decapita-
tion under sodium pentobarbital anesthesia (60 mg kg,
I.P.). Blood was collected, centrifuged for 15 mins at 1500
× g at 4°C and stored at -20°C for further analysis. Skeletal
muscle samples were collected from the left hind leg
quadriceps, snap frozen and stored at -80°C. All animal
procedures undertaken were approved by the University
of Auckland Animal Ethics Committee.
Plasma glucose was measured along with quality con-
trols using commercial kits (Roche Diagnostics Corp.; IN,
USA) on an auto-analyzer (Roche/Hitachi 9002 Analyzer;
Hitachi, Tokyo, Japan). Plasma insulin was determined by
a rat insulin ELISA (Mercodia; Uppsala, Sweden) follow-
ing the manufacturers' instructions. The insulin assay
sensitivity was 0.07 μg/l and the intra- and inter-assay
coefficients of variation (CVs) were 3.4% and 6.3%.
Protein extraction and Western blotting
Proteins were extracted from male and female D140 mus-
cle samples and Western blot analysis performed [11,12].
Antibodies from Santa Cruz Biotechnology (CA, USA)
were used for the detection of myostatin (1:3000 dilution;
Goat Polyclonal GDF-8 (F-13), Sc-34781) and FSTL-3
(1:5000 dilution; Goat Polyclonal FLRG (N-18), Sc-21302)
in conjunction with a secondary Polyclonal Rabbit Anti
IgG/HRP antibody (1:10000 dilution). The relative optical
densities were normalized to sheep muscle expression of
myostatin and FSTL-3 protein.
Statistical analysis
All analyses were run using a general linear mixed model
followed by Tukey's post hoc comparison performed on
SAS software version 9.1 (SAS institute, Cavy, NC). Dif-
ferences in bodyweight and composition, plasma metab-
olite concentrations and the relative expression of
myostatin and FSTL-3 in skeletal muscle were analysed
with group, sex and diet included in the model, and all
interactions between the main effects were analysed. All
data presented are as means ± SEM.
Results
Comparisons of D130 body composition are shown in
Table 1 and Table 2. Male offspring were heavier (P <
0.0001) than females (Table 1). Males and females were
heavier (P < 0.05) on an HF diet compared to their chow
fed contemporaries; the ADAD group was the heaviest
within HF fed animals (P < 0.01). A trend toward a higher
percentage of body fat in the males compared to females
Figure 1 The experimental design employed in this study. Gesta-
tional diets are represented by AD = ad libitum and UN = 30% of the ad 
libitum diet. Hatched boxes are males and in black are the females. The 
relative difference in body size between F2 generation males and fe-
males is represented diagrammatically.
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was observed with significance reached in the ADUN
chow and HF fed offspring (P < 0.05). HF fed offspring
had an elevated body fat percentage but lower lean body
percentage compared to chow-fed offspring. Interest-
ingly, both UNAD HF fed males and females had a lower
(P < 0.01) body fat percentage compared to ADAD con-
temporaries (Table 1). Differences in plasma glucose and
insulin concentrations were also evident between sexes
and groups (Table 2). Most strikingly an elevated glucose
concentration was seen in UNAD HF females (not males)
compared to all other groups.
Table 1: Mature female and male body weight, body fat percentage and lean body percentage.
Body weight Body fat % Lean Body %
Female Male Female Male Female Male
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Chow fed
ADAD 323.9 ± 10.4ax 564.6 ± 13.5ay 25.9 ± 2.2ax 27.0 ± 2.3acx 66.23 ± 2.93ax 66.64 ± 1.91ax
ADUN 273.5 ± 11.2bx 528.3 ± 12.2by 17.7 ± 2.0bx 24.9 ± 2.2acy 73.68 ± 0.61bx 69.38 ± 1.61abx
UNAD 305.5 ± 10.8adx 552.9 ± 8.4aby 23.4 ± 2.2abx 25.9 ± 2.2acx 67.70 ± 1.99abx 67.04 ± 1.57adx
High fat fed
ADAD 365.8 ± 10.4cx 692.5 ± 39.1cy 39.1 ± 2.2cx 40.9 ± 2.3bx 53.42 ± 3.79bcx 52.73 ± 1.62bx
ADUN 308.7 ± 
11.7bdx
621.6 ± 11.7dy 27.0 ± 2.2adx 41.4 ± 2.2by 64.63 ± 1.86ax 52.10 ± 1.21cy
UNAD 335.6 ± 10.8adx 636.7 ± 30.8ey 30.8 ± 2.2adx 32.5 ± 2.2cx 61.16 ± 2.00adx 61.68 ± 3.83adx
Body weight: Female ADAD chow (n = 15), ADUN chow (n = 13), UNAD chow (n = 14), ADAD high fat (n = 15), ADUN high fat (n = 12), UNAD 
high fat (n = 14); Male ADAD chow (n = 9), ADUN chow (n = 11), UNAD chow (n = 23), ADAD high fat (n = 9), ADUN high fat (n = 12), UNAD 
high fat (n = 22). Body fat and lean muscle percentage: Female ADAD chow (n = 10), ADUN chow (n = 9), UNAD chow (n = 10), ADAD high fat 
(n = 10), ADUN high fat (n = 10), UNAD high fat (n = 10); Male ADAD chow (n = 9), ADUN chow (n = 10), UNAD chow (n = 10), ADAD high fat 
(n = 10), ADUN high fat (n = 10), UNAD high fat (n = 10). Significant differences (P < 0.05) between the experimental groups are shown by 
letters a to e (read down column). Significant differences (P < 0.05) between genders shown by letters x and y (read across column).
Table 2: Mature female and male plasma insulin and glucose concentrations.
Insulin (μg/l) Glucose (mmol/l)
Female Male Female Male
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Chow fed
ADAD 2.2 ± 0.4abx 2.0 ± 0.6ax 8.6 ± 0.3ax 8.5 ± 0.4abx
ADUN 1.5 ± 0.4ax 3.5 ± 0.5bcy 8.3 ± 0.3ax 8.8 ± 0.4abx
UNAD 1.6 ± 0.4ax 2.5 ± 0.3aby 9.1 ± 0.3ax 8.1 ± 0.2ay
High fat fed
ADAD 2.9 ± 0.4bcx 4.0 ± 0.6bcx 8.7 ± 0.3ax 9.1 ± 0.4bx
ADUN 3.1 ± 0.5bcx 3.1 ± 0.5abcx 8.9 ± 0.3ax 8.1 ± 0.3ax
UNAD 3.6 ± 0.4cx 4.1 ± 0.3bcx 10.2 ± 0.3bx 9.4 b ± 0.2by
Insulin and glucose: Female ADAD chow (n = 9), ADUN chow (n = 7), UNAD chow (n = 6), ADAD high fat (n = 9), ADUN high fat (n = 6), UNAD 
high fat (n = 8); Male ADAD chow (n = 4), ADUN chow (n = 5), UNAD chow (n = 15), ADAD high fat (n = 4), ADUN high fat (n = 6), UNAD high 
fat (n = 14). Significant differences (P < 0.05) between the experimental groups are shown by letters a to e (read down column). Significant 
differences (P < 0.05) between genders shown by letters x and y (read across column).Peiris et al. Nutrition & Metabolism 2010, 7:44
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Figure 2 Myostatin precursor, dimer and FSTL-3 expression. (a) D140 female and male skeletal muscle tissue expression of myostatin precursor 
(50 kDa). Female ADAD chow (n = 3), ADUN chow (n = 4), UNAD chow (n = 7), ADAD high fat (n = 4), ADUN high fat (n = 4), UNAD high fat (n = 3); 
Male ADAD chow (n = 4), ADUN chow (n = 3), UNAD chow (n = 4), ADAD high fat (n = 2), ADUN high fat (n = 1), UNAD high fat (n = 5). (b) D140 female 
and male skeletal muscle tissue expression of myostatin dimer (28 kDa). Female ADAD chow (n = 6), ADUN chow (n = 7), UNAD chow (n = 7), ADAD 
high fat (n = 5), ADUN high fat (n = 6), UNAD high fat (n = 6); Male ADAD chow (n = 4), ADUN chow (n = 3), UNAD chow (n = 5), ADAD high fat (n = 
4), ADUN high fat (n = 3), UNAD high fat (n = 5). (c) D140 female and male skeletal muscle tissue expression of FSTL-3 (27 kDa). Female ADAD chow 
(n = 3), ADUN chow (n = 6), UNAD chow (n = 7), ADAD high fat (n = 5), ADUN high fat (n = 6), UNAD high fat (n = 5); Male ADAD chow (n = 4), ADUN 
chow (n = 3), UNAD chow (n = 4), ADAD high fat (n = 3), ADUN high fat (n = 3), UNAD high fat (n = 5). Females are represented by black bars and males 
by the hatched bars. The graphs are divided on either side of the dashed line by postnatal diet (chow or high fat fed) of offspring. Gestational diet is 
on the x-axis and relative expression of the proteins on the y-axis. Data given as mean optical densities relative to positive control, sheep muscle ± 
SEM. Significance is shown by the stars where P < 0.05 *, P < 0.01 **, P < 0.001***.
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Generally males displayed higher (P < 0.05) precursor
(Figure 2a) and dimer (Figure 2b) expression than
females, which was especially apparent (P < 0.01) in both
chow and HF UNAD, and to a lesser extent (P < 0.05) in
chow-fed ADUN animals. In females only, myostatin pre-
cursor and dimer expression was altered by both trans-
generational under-nutrition and postnatal diet, demon-
strated by the UNAD females having a lower (P < 0.05)
expression than ADAD and ADUN contemporaries and
the dimer expression of UNAD HF-fed females being
lower (P < 0.05) than UNAD chow-fed females. Overall
FSTL-3 expression did not differ between sexes, although
difference between sexes within certain treatments and
diets were evident (Figure 2c). Most notably, UNAD HF
females had higher (P < 0.05) FSTL-3 expression than
UNAD HF males and in fact, higher (P < 0.01) FSTL-3
expression compared to all other female groups.
Discussion
Sexually dimorphic differences were evident in the phe-
notypic measures investigated and notably, the skeletal
muscle expression of myostatin and FSTL-3 proteins. The
majority of these measures were also impacted upon by
gestational and trans-generational under-nutrition and
postnatal diet.
Generally higher myostatin precursor and dimer
expression was identified in the males compared to
females, whereas a consistent dimorphic difference in
FSTL-3 expression was not evident; with only a few spe-
cific groups within diet showing differences. The
increased expression of myostatin precursor in skeletal
muscle of males compared to females is in agreement
with studies in mice [13,14]. In contrast however to our
study, these studies in mice identified the myostatin
dimer expression, unlike the precursor, to be higher in
females, which is surprising since it would be expected
that both precursor and dimer had increased expression
in the same sex, as in the current study. Species specific
differences in myostatin dimer expression and the use of
different antibodies between the two studies in order to
detect the dimer, and thus potentially different binding
sites, may however explain the discrepancy.
I n  t h i s  s t u d y ,  i r r e s p e c t i v e  o f  s e x ,  t h e  e x p r e s s i o n  o f
FSTL-3, myostatin precursor and dimer were varied in
the UNAD HF fed offspring. This matches the pheno-
typic data, as UNAD animals fed an HF diet post-wean-
ing, irrespective of sex, were lighter and had a reduced
percentage body fat than ADAD animals, as well as
ADUN animals (males only). Recently, the finding that
myostatin maintained adipocytes at an immature state
and thus influenced fat mass [4], suggest myostatin can
affect two different processes; fat deposition and glucose
uptake. Phenotypic differences in body composition were
also linked to changes in plasma metabolite concentra-
tions, as plasma glucose and insulin concentrations were
elevated in the UNAD group (mainly in females) demon-
strating hyperglycaemia, compared to the two other
groups. Higher blood glucose concentrations, as evident
in diabetes, are known to lead to reduced body weight of
offspring [15,16]. The increased plasma glucose concen-
trations evident in UNAD offspring could be influenced
by the expression of myostatin and FSTL-3 in skeletal
muscle, with limited fiber number and size potentially
restricting uptake of glucose from the circulation,
although further studies are needed to examine this
hypothesis. If true, myostatin may be a possible mediator
of offspring metabolic and physical phenotype.
Conclusion
Myostatin and FSTL-3 are sexually dimorphic in their
expression and both are also affected by gestational and
trans-generational under-nutrition. Thus myostatin may
be a key mediator of the effects of maternal under-nutri-
tion; altering fetal development, the mature phenotype of
offspring, and even the phenotype of subsequent genera-
tions. Further study of myostatin may provide a novel
therapeutic pathway for the treatment of metabolic disor-
ders; however, it is vital that the influence of nutrition
and gender should be taken into consideration.
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